NeuroPsy InfoHub adună studii și articole verificate editorial despre sănătate mintală și afecțiuni neurologice — pentru pacienți, familii și specialiști.
An FDA-approved rheumatoid arthritis drug that blocks IL-6 receptors significantly reduced excessive alcohol consumption in alcohol-dependent female mice by suppressing neuroinflammation in the central amygdala. This mechanism aligns with elevated IL-6 expression observed in postmortem brain tissue from individuals with alcohol use disorder, suggesting a potential therapeutic target.
A study of 287 MS brain tissue samples from the Netherlands Brain Bank identifies specific pathological features, including broad rim lesions and myelin repair failures, that explain variability in disease progression. Individual genetic backgrounds modulate these pathological processes, offering insights into why MS progresses differently among patients.
Researchers developed a carbon-fiber nanosensor capable of distinguishing Autism Spectrum Disorder from Intellectual Disability by measuring real-time nitric oxide production in patient-derived stem cells. This approach successfully differentiates the two conditions even when they share identical genetic mutations, offering a potential biomarker-based diagnostic tool.
Researchers at Texas A&M University developed a novel mouse model using Theiler's murine encephalomyelitis virus (TMEV) infection to generate Parkinson's disease symptoms without genetic modification or toxic injection. This approach provides a more naturalistic animal model to investigate the hypothesis that viral infection may trigger Parkinson's disease development in humans.
University of Otago research published in the Journal of Biomechanics demonstrates that smart mouthguard systems use standardized models that fail to account for biological variation across different sexes, ages, and body sizes. This limitation may result in serious traumatic brain injuries being undetected during impact assessment in rugby players.
